- Generic name
- Fluvoxamine Maleate
- Strength
- 100 mg
- Dosage form
- Extended Release Capsule
- Manufactured by
- Renata PLC.
Voxamin XR-100 Extended Release Capsule
About Voxamin XR-100 Extended Release Capsule
Voxamin XR-100 is made by Renata PLC. It is an extended release capsule that contains 100 mg of fluvoxamine maleate, a medicine from the SSRI group used in certain mental health conditions.
There are 4 brands of Fluvoxamine Maleate listed in Bangladesh.
What is Voxamin XR-100 Extended Release Capsule?
Voxamin XR-100 is an extended release capsule from Renata PLC. that contains 100 mg of fluvoxamine maleate. Fluvoxamine belongs to the SSRI group of antidepressants. It works on serotonin, a chemical messenger in the brain, by slowing its reabsorption into nerve cells. Extended release means the capsule is designed to release the medicine over a longer period than a plain tablet, which is why it should be swallowed whole rather than crushed or chewed. It is a prescription medicine, so the doctor decides the dose and how long it is taken.
Uses of Voxamin XR-100
Fluvoxamine maleate is used in obsessive-compulsive disorder. It is also used in depressive illness, panic disorder, eating disorders and chronic tension headache. This is a prescription medicine, so it should only be taken when a doctor has prescribed it for you. Ask the doctor if you are unsure why it has been prescribed or what it is expected to do in your case.
How to use Voxamin XR-100
Swallow the extended release capsule whole with water. Do not crush, chew or open it, because that can change how the medicine is released. The doctor decides the dose, when to take it and how long the course lasts; follow those instructions exactly. If you miss a dose or are unsure about anything, ask your doctor or pharmacist rather than changing the schedule yourself. Do not stop suddenly unless the doctor tells you to.
Side effects of Voxamin XR-100
Common side effects reported with fluvoxamine include nausea, drowsiness, insomnia, weakness, nervousness, indigestion, sweating, loss of appetite, tremor and vomiting. Some people also report dry mouth, changed taste, rash, agitation or changes in sexual function. This is not a complete list. Tell your doctor or pharmacist if any side effect bothers you or does not go away, and seek medical help for anything severe.
Safety and precautions
Tell your doctor before starting if you have a history of mania, seizures, suicidal thoughts, heart disease, diabetes, angle-closure glaucoma, bleeding problems, or liver or kidney problems. Fluvoxamine may affect alertness, so be careful with driving and skilled tasks until you know how it affects you. Do not take it with MAOIs or certain other medicines; your doctor will check for interactions. In pregnancy, the risks and benefits need to be weighed, and fluvoxamine passes into breast milk. Ask your doctor first if you are pregnant, planning pregnancy or breastfeeding.
Frequently asked questions
What does extended release capsule and 100 mg mean?
Extended release means the capsule releases the medicine gradually over time instead of all at once, so it should be swallowed whole. The 100 mg refers to the amount of fluvoxamine maleate in each capsule. The doctor decides how it should be taken.
What is Voxamin XR-100 used for and what kind of medicine is it?
It contains fluvoxamine maleate, an SSRI antidepressant. It is used in obsessive-compulsive disorder, depressive illness, panic disorder, eating disorders and chronic tension headache. It is a prescription medicine, so it should be used only under a doctor's guidance.
How should Voxamin XR-100 be stored?
Keep the capsules below 30°C, away from light and moisture, and out of the reach of children. Do not use them after the expiry date. If you are unsure how to store it, ask your pharmacist.
Can I stop taking Voxamin XR-100 on my own?
Do not stop or change the medicine without talking to your doctor first. The doctor decides the dose, the course and how to stop it safely. If you have missed doses or feel unwell, contact your doctor or pharmacist for advice.
Indications
- Obsessive-Compulsive Disorder
- Depressive illness
- Panic Disorder
- Eating Disorders
- Chronic Tension Headache
Pharmacology
Dosage & Administration
Pediatric Population (children and adolescents): The recommended starting dose for Fluvoxamine Maleate Tablets in pediatric populations (ages 8-17 years) is 25 mg, administered as a single daily dose at bedtime. In a controlled clinical trial establishing the effectiveness of Fluvoxamine Maleate Tablets in OCD, pediatric patients (ages 8-17) were titrated within a dose range of 50 to 200 mg/day. Physicians should consider age and gender differences when dosing pediatric patients. The maximum dose in children up to age 11 should not exceed 200 mg/day. Therapeutic effects in female children may be achieved with lower doses. Dose adjustment in adolescents (up to the adult maximum dose of 300 mg) may be indicated to achieve therapeutic benefit. The dose should be increased in 25 mg increments every 4 to 7 days, as tolerated until the maximum therapeutic benefit is achieved. It is advisable that a total daily dose of more than 50 mg should be given in two divided doses. If the two divided doses are not equal, the larger dose should be given at bedtime.
Elderly or Hepatically Impaired Patients: Elderly patients and those with hepatic impairment have been observed to have a decreased clearance of fluvoxamine maleate. Consequently, it may be appropriate to modify the initial dose and the subsequent dose titration for these patient groups.
Interaction
Carbamazepine: Elevated carbamazepine levels and symptoms of toxicity with coadministration (7.2).
Sumatriptan: Rare postmarketing reports of weakness, hyperreflexia, and incoordination following use of an SSRI and sumatriptan. Monitor appropriately if concomitant treatment is clinically warranted.
Tacrine: Coadministration increased tacrine C max and AUC five- and eight-fold and caused nausea, vomiting, sweating, and diarrhea.
Tricyclic Antidepressants (TCAs): Coadministration significantly increased plasma TCA levels. Use caution; monitor plasma TCA levels; reduce TCA dose if indicated.
Tryptophan: Severe vomiting with coadministration.
Diltiazem: Bradycardia with coadministration.
Propranolol or metoprolol: Reduce dose if coadministered and titrate more cautiously
Contraindications
Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with Fluvoxamine Maleate Tablets or within 14 days of stopping treatment with Fluvoxamine Maleate Tablets. Do not use
Fluvoxamine Maleate Tablets within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start Fluvoxamine Maleate Tablets in a patient who is being treated with linezolid or intravenous methylene blue.
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Storage Conditions
Alternative brands of Fluvoxamine Maleate
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.